AOS - AOS

Ultime notizie per A.O. Smith (NYSE:AOS) Azioni

SMITH (A.O.) CORP

A.O. Smith

A.O. Smith manufactures a broad lineup of water heaters, boilers, and water treatment products. The company has two reporting segments: North America (75% of sales) and rest of world (25% of sales). A.O. Smith is the leading manufacturer of water heaters in North America for the residential and commercial markets, with approximately 37% and 54% market share, respectively. Residential water heaters account for Most of North American sales and are distributed equally through wholesale and retail channels. Most of A.O. Smith's international revenue is from China, a market the company entered during the mid-1990s.

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

PAYX

Analisi delle principali azioni industriali da considerare per gli investimenti di dicembre 2024. Ecco quali sono.

Le 3 migliori azioni industriali da acquistare a dicembre 2024

A.O. Smith Corp

Alpha and Omega Semiconductor Limited - Common Shares

Alpha & Omega Semiconductor Ltd

<p>A March filing shows that Representative April McClain Delaney reported a sale in A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>), valued between $54,012 and $285,000. The transaction date is listed as March 20, 2025, with the report published on March 20, 2025.</p>
<p>At present, A.O. Smith shares are trading down 0.0% at $66.71.</p>
<h3>Representative's Recent Trading Activity</h3>
<p>In the past three years, April McClain Delaney made 38 stock trades totaling more than $94 thousand. The largest trades involved stocks like A.O. Smith and Corpay. Their most notable trades made recently include key transactions: </p>
<ul>
<li><strong>Corpay (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPAY#NYSE">CPAY</a>):</strong> $15,001 - $50,000 Purchase</li>
<li><strong>Revvity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVTY#NYSE">RVTY</a>):</strong> $15,001 - $50,000 Sale</li>
<li><strong>Teledyne Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDY#NYSE">TDY</a>):</strong> $15,001 - $50,000 Purchase</li>
</ul>
<p>Here's a summary of April McClain Delaney's recent trades:</p>
<table>
<thead>
<tr>
<th><strong>Company</strong></th>
<th><strong>Ticker</strong></th>
<th><strong>Stock Type</strong></th>
<th><strong>Amount</strong></th>
<th><strong>Transaction Type</strong></th>
<th><strong>Transaction Date</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>Corpay</td>
<td>CPAY</td>
<td>STOCK</td>
<td>$15,001 - $50,000</td>
<td>P</td>
<td>2025-02-28</td>
</tr>
<tr>
<td>Labcorp Hldgs</td>
<td>LH</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2025-02-28</td>
</tr>
<tr>
<td>Revvity</td>
<td>RVTY</td>
<td>STOCK</td>
<td>$15,001 - $50,000</td>
<td>S</td>
<td>2025-02-28</td>
</tr>
<tr>
<td>Tempur Sealy International, Inc.</td>
<td>TPX</td>
<td></td>
<td>$1,001 - $15,000</td>
<td>S (Partial)</td>
<td>2025-02-28</td>
</tr>
<tr>
<td>CACI International</td>
<td>CACI</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2025-02-27</td>
</tr>
</tbody>
</table>
<p>To keep an eye on April McClain Delaney's trades and other government stock activity, check out our <a href="https://www.benzinga.com/gov-trades/members/april-mcclain-delaney"><strong>real-time tracking tool</strong></a>!</p>
<h3>Why Congressional Transactions Matter</h3>
<p>A congressional transaction is when any representative or senator either buys or sells an individual stock.</p>
<p>Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.</p>
<p>In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.</p>
<h3>The Importance of Congressional Transactions</h3>
<p>Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.</p>
<p>When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.</p>
<p>A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Government

Politics

General

CPAY

RVTY

Maryland Rep. April McClain Delaney Sold Over $54K Worth of A.O. Smith Stock: Here's What You Should Know

<p>In the last three months, 7 analysts have published ratings on A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>), offering a diverse range of perspectives from bullish to bearish.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for A.O. Smith, presenting an average target of $81.57, a high estimate of $90.00, and a low estimate of $73.00. A decline of 4.41% from the prior average price target is evident in the current average. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738357268_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>A clear picture of A.O. Smith's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Damian Karas</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$74.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Bryan Blair</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$84.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$84.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Bryan Blair</td>
<td>Oppenheimer</td>
<td>Announces</td>
<td>Outperform</td>
<td>$88.00</td>
<td>-</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$73.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$90.00</td>
<td>$91.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$78.00</td>
<td>$85.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to A.O. Smith. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of A.O. Smith compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of A.O. Smith's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/AOS/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on A.O. Smith analyst ratings.</strong></a></p>
<h2>Delving into A.O. Smith's Background</h2>
<p>A.O. Smith Corporation manufactures a broad lineup of water heaters, boilers, and water treatment products. The company has two reporting segments, North America (75% of sales) and rest of world (25% of sales). A.O. Smith is the leading manufacturer of water heaters in North America for both residential and commercial markets, with approximately 37% and 54% market share, respectively. Residential water heaters account for Most of North American sales and are distributed equally through wholesale and retail channels. Most of A.O. Smith's international revenue is from China, a market the company entered during the mid-1990s.</p>
<h3>Breaking Down A.O. Smith's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Revenue Challenges:</strong> A.O. Smith's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately <strong>-3.72%</strong>. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> A.O. Smith's net margin is impressive, surpassing industry averages. With a net margin of <strong>13.31%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> A.O. Smith's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>6.27%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> A.O. Smith's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>3.78%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.07</strong>.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

What 7 Analyst Ratings Have To Say About A.O. Smith

<p>UBS  analyst Damian Karas   maintains A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) with a Neutral and lowers the price target from $80 to $74.</p>


Price Target

UBS Maintains Neutral on A.O. Smith, Lowers Price Target to $74

<p>Oppenheimer  analyst Bryan Blair   maintains A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) with a Outperform and lowers the price target from $88 to $84.</p>


Oppenheimer Maintains Outperform on A.O. Smith, Lowers Price Target to $84

<p>Stifel  analyst Nathan Jones   maintains A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) with a Buy and lowers the price target from $90 to $84.</p>


Stifel Maintains Buy on A.O. Smith, Lowers Price Target to $84

WIIM

A.O. Smith shares are trading lower after the company missed Q4 financial estimates and issued FY25 sales guidance below estimates.

<p><strong>Outlook</strong></p>
<p>2025 Outlook<br /><br />(in millions, except per share amounts)</p>
<p><figure class="table"><br />
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1"><br /><br />&nbsp;</td>
<td colspan="1" rowspan="1">2024</td>
<td colspan="1" rowspan="1"><br /><br />&nbsp;</td>
<td colspan="2" rowspan="1">2025 Outlook</td>
</tr>
<tr>
<td colspan="1" rowspan="1"><br /><br />&nbsp;</td>
<td colspan="1" rowspan="1">Actual</td>
<td colspan="1" rowspan="1"><br /><br />&nbsp;</td>
<td colspan="1" rowspan="1">Low End</td>
<td colspan="1" rowspan="1">High End</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net sales</td>
<td colspan="1" rowspan="1">$&nbsp;&nbsp;&nbsp;&nbsp; 3,818</td>
<td colspan="1" rowspan="1"><br /><br />&nbsp;</td>
<td colspan="1" rowspan="1">$&nbsp;&nbsp; 3,800</td>
<td colspan="1" rowspan="1">$&nbsp;&nbsp; 3,900</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Diluted earnings per share</td>
<td colspan="1" rowspan="1">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.63</td>
<td colspan="1" rowspan="1"><br /><br />&nbsp;</td>
<td colspan="1" rowspan="1">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.60</td>
<td colspan="1" rowspan="1">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.90</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted earnings per share&nbsp; &nbsp;</td>
<td colspan="1" rowspan="1">$&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; 3.73 5</td>
<td colspan="1" rowspan="1"><br /><br />&nbsp;</td>
<td colspan="1" rowspan="1">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.60</td>
<td colspan="1" rowspan="1">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.90</td>
</tr>
</tbody>
</table>
<p></p></figure><figure class="table"><br />
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1"><br /><br />&nbsp;</td>
<td colspan="1" rowspan="1"><br /><br />&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">5</td>
<td colspan="1" rowspan="1">Excludes restructuring and impairment expenses. See accompanying GAAP to Non-GAAP reconciliations</td>
</tr>
</tbody>
</table>
<p></p></figure>
</p><p>"Our outlook for 2025 projects our consolidated sales to be flat to up 2% compared to 2024. We expect our full-year EPS to be between $3.60 and $3.90, slightly higher than 2024 at the mid-point. In North America, we anticipate water heater industry unit volumes to be flat year-over-year with less first half versus second half volatility compared to 2024. In our Rest of World segment, we expect a single-digit sales decline in China as consumer demand remains low. We project continued double-digits sales growth in India," stated Wheeler.</p>
<p>"We believe our strong balance sheet and free cash flow continue to provide us the liquidity to focus on our capital allocation priorities of organic growth, acquisitions, dividends and share repurchases, which we believe will enable us to execute our strategy to invest and grow profitably."</p>


Earnings

Guidance

A. O. Smith For 2025 Expects Net Sales Of $3.8B-$3.9B Vs. $3.997B Est.; Sees Adj. EPS Of $3.60-$3.90 Vs. $4.03 Est.

<p>A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) reported quarterly earnings of $0.85 per share which missed the analyst consensus estimate of $0.89 by 4.49 percent. This is a 12.37 percent decrease over earnings of $0.97 per share from the same period last year.  The company reported quarterly sales of $912.400 million which missed the analyst consensus estimate of $954.008 million by 4.36 percent.  This is a 7.66 percent decrease over sales of $988.100 million the same period last year.</p>


Earnings Misses

A.O. Smith Q4 2024 Adj. EPS $0.85 Misses $0.89 Estimate, Sales $912.400M Miss $954.008M Estimate

AAPL

ABCB

ALGM

APPF

Adtalem Global Education Inc. Common Stock

ATGE

BAFN

BBVA

BHLB

BOOT

CACC

CHKP

CIVB

CMCSA

CNOB

COUR

CSWI

CVCO

DECK

FBIZ

FCFS

FFWM

FINW

FISI

FLWS

FRME

GSIT

INTC

KLAC

KRNY

LPLA

MBLY

MBUU

NTCT

ONEW

PFSI

REAL

SCSC

SHEL

SILC

SIRI

SKYW

STBA

STEL

Earnings Scheduled For January 30, 2025

<p>Oppenheimer  analyst Bryan Blair   upgrades A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) from Perform to Outperform and announces $88 price target.</p>


Upgrades

Oppenheimer Upgrades A.O. Smith to Outperform, Announces $88 Price Target

<p>During the last three months, 7 analysts shared their evaluations of A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $81.86, a high estimate of $91.00, and a low estimate of $73.00. Highlighting a 2.35% decrease, the current average has fallen from the previous average price target of $83.83. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1736805611_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>The standing of A.O. Smith among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$73.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$90.00</td>
<td>$91.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$78.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$91.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Michael Halloran</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$81.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Damian Karas</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$80.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Matt Summerville</td>
<td>DA Davidson</td>
<td>Announces</td>
<td>Neutral</td>
<td>$80.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to A.O. Smith. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of A.O. Smith compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of A.O. Smith's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into A.O. Smith's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/AOS/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on A.O. Smith analyst ratings.</strong></a></p>
<h2>All You Need to Know About A.O. Smith</h2>
<p>A.O. Smith Corporation manufactures a broad lineup of water heaters, boilers, and water treatment products. The company has two reporting segments, North America (75% of sales) and rest of world (25% of sales). A.O. Smith is the leading manufacturer of water heaters in North America for both residential and commercial markets, with approximately 37% and 54% market share, respectively. Residential water heaters account for Most of North American sales and are distributed equally through wholesale and retail channels. Most of A.O. Smith's international revenue is from China, a market the company entered during the mid-1990s.</p>
<h3>Financial Insights: A.O. Smith</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, A.O. Smith faced challenges, resulting in a decline of approximately <strong>-3.72%</strong> in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.</p>
<p><strong>Net Margin:</strong> A.O. Smith's net margin excels beyond industry benchmarks, reaching <strong>13.31%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> A.O. Smith's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>6.27%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> A.O. Smith's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>3.78%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> A.O. Smith's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.07</strong>.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


<p>Citigroup  analyst Andrew Kaplowitz   maintains A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) with a Neutral and lowers the price target from $78 to $73.</p>


Citigroup Maintains Neutral on A.O. Smith, Lowers Price Target to $73

<p>The most oversold stocks in the industrials sector presents an opportunity to buy into undervalued companies.</p>
<p>The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.</p>
<p>Here's the latest list of major oversold players in this sector, having an RSI near or below 30.</p>
<h3 class="wp-block-heading"><strong>Paychex Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>)</strong></h3>
<ul>
<li>On Nov. 19, JP Morgan analyst Tien-Tsin Huang maintained Paychex with an Underweight rating and raised the price target from $133 to $139. The company's stock fell around 4% over the past five days and has a <a href="https://www.benzinga.com/quote/PAYX">52-week low of $114.72</a>.</li>
<li><strong>RSI Value:</strong> 29.58&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li><strong>PAYX Price Action:</strong> Shares of Paychex fell 3.2% to close at $135.86 on Wednesday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121924&amp;t=be2bearmibe3na1">latest PAYX news</a>. </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="908" height="850" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074317/image-164.png" alt="" class="wp-image-699579" style="width:617px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074317/image-164.png 908w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074317/image-164-300x281.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074317/image-164-768x719.png 768w" sizes="(max-width: 908px) 100vw, 908px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>Sunrun Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></h3>
<ul>
<li>On Dec. 17, Goldman Sachs analyst Brian Lee maintained Sunrun with a Buy and lowered the price target from $19 to $17. The company's stock fell around 12% over the past five days and <a href="https://www.benzinga.com/quote/RUN">has a 52-week low</a> of $9.13.</li>
<li><strong>RSI Value:</strong> 28.40</li>
<li><strong>RUN Price Action:</strong> Shares of Sunrun fell 9.1% to close at $9.15 on Wednesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121924&amp;t=be2bearmibe3na1"> trend in RUN stock</a>. </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="916" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074410/image-165.png" alt="" class="wp-image-699581" style="width:630px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074410/image-165.png 916w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074410/image-165-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074410/image-165-768x706.png 768w" sizes="(max-width: 916px) 100vw, 916px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>A O Smith Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>)</strong></h3>
<ul>
<li>On Dec. 11, Stifel analyst Nathan Jones maintained A.O. Smith with a Buy and lowered the price target from $91 to $90. The company's stock fell around 5% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/AOS">low of $68.89.</a></li>
<li><strong>RSI Value:</strong> 25.09</li>
<li><strong>AOS Price Action:</strong> Shares of A O Smith fell 2.7% to close at $68.91 on Wednesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121924&amp;t=be2bearmibe3na1">breakout in AOS shares</a>. </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="927" height="836" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074507/image-166.png" alt="" class="wp-image-699582" style="width:567px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074507/image-166.png 927w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074507/image-166-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074507/image-166-768x693.png 768w" sizes="(max-width: 927px) 100vw, 927px" /></a></figure></p>
<p><strong>Read This Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/24/12/42553288/top-3-tech-and-telecom-stocks-that-may-crash-this-month">Top 3 Tech And Telecom Stocks That May Crash This Month</a></strong></li>
</ul>


Top 3 Industrials Stocks Which Could Rescue Your Portfolio For December

<p>Throughout the last three months, 6 analysts have evaluated A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>), offering a diverse set of opinions from bullish to bearish.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $83.33, a high estimate of $91.00, and a low estimate of $78.00. This current average has decreased by 1.96% from the previous average price target of $85.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1733929267_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>The analysis of recent analyst actions sheds light on the perception of A.O. Smith by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$90.00</td>
<td>$91.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$78.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$91.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Michael Halloran</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$81.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Damian Karas</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$80.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Matt Summerville</td>
<td>DA Davidson</td>
<td>Announces</td>
<td>Neutral</td>
<td>$80.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to A.O. Smith. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of A.O. Smith compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of A.O. Smith's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>To gain a panoramic view of A.O. Smith's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/AOS/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on A.O. Smith analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind A.O. Smith</h2>
<p>A.O. Smith Corporation manufactures a broad lineup of water heaters, boilers, and water treatment products. The company has two reporting segments, North America (75% of sales) and rest of world (25% of sales). A.O. Smith is the leading manufacturer of water heaters in North America for both residential and commercial markets, with approximately 37% and 54% market share, respectively. Residential water heaters account for Most of North American sales and are distributed equally through wholesale and retail channels. Most of A.O. Smith's international revenue is from China, a market the company entered during the mid-1990s.</p>
<h3>Financial Insights: A.O. Smith</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Revenue Challenges:</strong> A.O. Smith's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately <strong>-3.72%</strong>. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> A.O. Smith's net margin is impressive, surpassing industry averages. With a net margin of <strong>13.31%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>6.27%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> A.O. Smith's ROA excels beyond industry benchmarks, reaching <strong>3.78%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> A.O. Smith's debt-to-equity ratio is below the industry average at <strong>0.07</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Where A.O. Smith Stands With Analysts

<p>Stifel  analyst Nathan Jones   maintains A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) with a Buy and lowers the price target from $91 to $90.</p>


Stifel Maintains Buy on A.O. Smith, Lowers Price Target to $90

<p>Citigroup  analyst Andrew Kaplowitz   maintains A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) with a Neutral and lowers the price target from $85 to $78.</p>


Citigroup Maintains Neutral on A.O. Smith, Lowers Price Target to $78

<h3 class="wp-block-heading">New On The Block</h3>
<p><strong>Evolent Health Inc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVH#NYSE">EVH</a>) is <a href="https://www.benzinga.com/m-a/24/08/40529349/evolent-health-explores-sale-garners-inbound-interest-from-private-equity-firms">reportedly up for sale</a>. The Arlington, Virginia-based software provide initiated an auction process after receiving takeover inquiries. Among the potential suitors are <strong>TPG Inc </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>), <strong>Clayton, Dubilier &amp; Rice</strong>, and <strong>KKR &amp; Co. Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>). Reuters reported that health insurer <strong>Elevance Health</strong> <strong>Inc </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>) may join forces with a private equity partner to pursue a deal.</p>
<p><strong>Kronos Bio Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRON#NASDAQ">KRON</a>), a company focused on developing therapies for cancer, is exploring &#8220;strategic alternatives,&#8221; including an acquisition or merger.The San Mateo, Califonia-based company reported $124.9 million in cash reserves as of Sept. 30. </p>
<p><strong>Saint-Gobain</strong> (PARIS:<a class="ticker" href="https://www.benzinga.com/stock/SGO#PARIS">SGO</a>) is considering a sale of its auto glass unit, which could fetch up to 2.5 billion euro ($2.6 billion), per <a href="https://www.bloomberg.com/news/articles/2024-11-13/st-gobain-is-said-to-weigh-2-5-billion-sale-of-auto-glass-unit">Bloomberg</a>. The company is reportedly considering this strategic move as part of its broader business evaluation. This sale aligns with Saint-Gobain&#8217;s efforts to streamline its operations and focus on core business areas.</p>
<p><strong>Shell </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>) is seeking to <a href="https://www.bloomberg.com/news/articles/2024-11-13/shell-aims-to-sell-majority-stake-in-carbon-offsets-business?srnd=phx-deals">jettison</a> a majority of its carbon offsets portfolio. The company first launched the portfolio of offsets, which covers dozens of projects, <a href="https://www.bloomberg.com/news/features/2023-08-31/shell-silently-abandoned-its-100-million-a-year-plan-to-offset-co2-emissions" target="_blank" rel="noreferrer noopener">in 2018</a>. </p>
<p><strong>Unilever</strong> (LSE: ULVR) is exploring the sale of some Dutch food brands, including Unox soups and Conimex seasonings. According to Reuters, the company will instead focus on its biggest &#8220;power&#8221; labels.</p>
<p><strong>See Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/42024210/benzinga-bulls-and-bears-tesla-disney-gold-and-hedge-funds-project-bitcoin-to-hit-100k-150k">Benzinga Bulls And Bears: Tesla, Disney, Gold — And Hedge Funds Project Bitcoin To Hit $100K-$150K</a></strong></p>
<h3 class="wp-block-heading">Bankruptcy Block</h3>
<p><strong>Alex Jones&#8217;</strong>s media company, Infowars, is now the property of satirical publication <strong>The Onion</strong>. The publication&#8217;s backers were none other than the families <a href="https://www.benzinga.com/media/24/11/41982446/jokes-on-jones-onion-backed-by-families-of-sandy-hook-victims-buys-info-wars">of Sandy Hook victims</a>. Observers praised the deal as poetic justice, considering Jones owes over $1 billion in defamation judgments against those families. Jones, who <a href="https://www.benzinga.com/news/23/12/36168941/elon-musks-controversial-move-alex-jones-returns-to-x-after-user-vote">has garnered sympathy from</a> right-wing personalities like<strong> Elon Musk</strong> and <strong>Tucker Carlson</strong>, confirmed the acquisition in a visibly distressed social media video, blaming &#8220;Democrats.&#8221;</p>
<p><strong>Diamond Sports Group</strong>&#8216;s restructuring will include reducing its debt from nearly $9 billion to $200 million, <a href="https://www.espn.com/mlb/story/_/id/42388454/diamond-sports-group-emerges-bankruptcy">ESPN</a> reports. The restructuring plan received what Diamond categorized as &#8220;nearly unanimous support&#8221; from debt holders. Diamond, currently possessing $100 million in liquidity, will emerge from bankruptcy and operate as a stand-alone entity. <strong>Sinclair</strong>, the parent company, took on $8 billion in debt to buy regional channels from <strong>Fox</strong> for $10.6 billion in 2019. That debt contributed to Diamond&#8217;s bankruptcy.</p>
<h3 class="wp-block-heading">Updates From The Block</h3>
<p>Currently, there are no concrete indications that <strong>Humana Inc. </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) is actively pursuing a sale. Recent speculation regarding Humana being acquired by <strong>Cigna Group</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) was definitively addressed, with Cigna explicitly stating that it is <a href="https://www.benzinga.com/general/health-care/24/11/41877573/cigna-not-pursuing-humana-merger-stock-soars">not pursuing a merger</a> with Humana at this time. This clarification came after rumors reignited post-election, driven by the potential for more lenient antitrust reviews under the new <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41979935/golden-years-for-ma-deals-ahead-under-trump-analysts-highlight-top-10-large-cap-candidates">Republican administration and Congress</a>.</p>
<p><strong>Spirit Airlines</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAVE#NYSE">SAVE</a>) is no longer in deal talks with <strong>Frontier Airlines</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULCC#NASDAQ">ULCC</a>). It&#8217;s now in advanced discussions with bondholders to finalize a bankruptcy plan. The carrier continues to struggle with mounting losses and looming debt maturities. A bankruptcy filing is expected to happen within weeks, according to <a href="https://www.benzinga.com/news/earnings/24/11/41932146/spirit-airlines-nears-bankruptcy-creditors-may-approve-equity-cancellation-heres-what-it-means-for-investors-as-shares-fall-with-a-thud">the Wall Street Journal</a>.</p>
<p><strong>MEI Pharma, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEIP#NASDAQ">MEIP</a>) continues to explore M&amp;A opportunities, hiring <strong>Oppenheimer &amp; Co.</strong>, Inc. as an exclusive financial advisor to assist the process. During the first quarter of fiscal year 2025, the company commenced cash preservation efforts that include a reduction-in-force, which will continue in stages as the Company's operational and strategic direction evolves.</p>
<h3 class="wp-block-heading">Notes From The Block</h3>
<p>Wall Street anticipates a surge in M&amp;A as Republicans take control of Congress and deregulate. Analysts expect Federal Trade Commission Chair <strong>Lina Khan</strong>'s removal, which could ease antitrust scrutiny. Bank of America highlights that Republican administrations, like President-elect <strong>Donald Trump</strong>&#8216;s, historically foster over 50% more financial sector M&amp;A activity compared to Democratic ones. </p>
<p>Bank of America also predicts that 2025 could mark a better year for M&amp;A as rate cuts take effect and economic conditions stabilize. Here&#8217;s a list of five potential targets the bank compiled. For the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41979935/golden-years-for-ma-deals-ahead-under-trump-analysts-highlight-top-10-large-cap-candidates">full list, click here</a>.</p>
<p><figure class="wp-block-table"><br />
<table>
<thead>
<tr>
<th>Company</th>
<th>Sector</th>
<th>Market Cap ($M)</th>
<th>Free Cash Flows-to-Enterprise Value (%)</th>
<th>Long-Term Growth Expectations (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Universal Health Services Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>)</td>
<td>Health Care</td>
<td>13,932</td>
<td>4.4</td>
<td>25.3</td>
</tr>
<tr>
<td><strong>Ralph Lauren</strong><strong>Corp.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RL#NYSE">RL</a>)</td>
<td>Consumer Disc.</td>
<td>12,473</td>
<td>5.99</td>
<td>10.5</td>
</tr>
<tr>
<td><strong>Paramount Global</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NYSE">PARA</a>)</td>
<td>Comm. Services</td>
<td>7,250</td>
<td>3.4</td>
<td>46.4</td>
</tr>
<tr>
<td><strong>Jabil Inc. </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>)</td>
<td>Technology</td>
<td>14,480</td>
<td>6.39</td>
<td>12.7</td>
</tr>
<tr>
<td><strong>Hasbro Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAS#NASDAQ">HAS</a>)</td>
<td>Consumer Disc.</td>
<td>9,215</td>
<td>3.6</td>
<td>27.5</td>
</tr>
</tbody>
</table>
<p></p></figure></p>
<p><em>For last week&#8217;s Deal Dispatch, <a href="https://www.benzinga.com/news/asset-sales/24/11/41866114/deal-dispatch-prison-companies-in-focus-post-election-tripadvisor-boasts-11b-in-cash">click here</a>.</em></p>
<p><strong>Now Read: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/equities/24/11/41699259/nvidia-rides-ai-wave-to-replace-intel-on-dow-jones-industrial-average-ending-its-25-year-run">Nvidia Rides AI Wave To Replace Intel On Dow Jones Industrial Average, Ending Its 25-Year Run</a></strong></li>
</ul>


AAUKF

APTV

ATSG

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

FFIV

KRON

MEIP

NISTF

PARA

PARIS:SGO

ROIC

SAVE

SLGWF

SLNG

TRIP

TSX:SGO

ULCC

Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul

<p>With Republicans taking control of Congress, Wall Street is buzzing about a potential boom in mergers and acquisitions (M&amp;A) under the upcoming<a href="https://www.benzinga.com/topic/donald-trump"><strong> Trump</strong> administration.</a></p>
<p>Bank of America analysts see brighter days ahead for deal-making, anticipating that Trump could remove Federal Trade Commission Chair <strong>Lina Khan</strong>, whose aggressive antitrust stance has been a major roadblock for M&amp;A activity across sectors.</p>
<p>Combined with favorable macro factors and investor demand for capex and M&amp;A over debt paydown, there are plenty of reasons to believe that 2025 and beyond could see significant deal activity.</p>
<h3 class="wp-block-heading">Banks And Biotech: Two Key Sectors To Watch</h3>
<p>Analysts at Bank of America's U.S. banks team are particularly bullish about the M&amp;A prospects for financials, which have historically enjoyed more than 50% higher deal activity under Republican administrations than Democratic ones. With regulatory scrutiny expected to loosen, the landscape is ripe for a surge in bank deals.</p>
<p>Deal activity in biotech has already started picking up, especially in smaller acquisitions. Big Pharma faces mounting pressure to offset patent expirations, so it&#8217;s hunting for acquisition targets to replenish its drug pipelines. Lower rates and potential deregulation could further fuel biotech M&amp;A as we head into 2025.</p>
<p>"The election results could lead to a less restrictive regulatory environment, which may open the door for more bank mergers and acquisitions,&#8221; <strong>Jill Carey Hall</strong>, CFA, a Bank of America analyst, said. </p>
<h3 class="wp-block-heading">Macro Factors: Green And Yellow Lights for M&amp;A</h3>
<p>Several macroeconomic factors support a cyclical pick-up in M&amp;A activity. </p>
<p>Strong equity market returns, cheap small-cap valuations relative to large caps and tight credit spreads all suggest a favorable environment for deal-making.</p>
<p>Not all signals are flashing green. Slowing GDP growth, rate uncertainty and high volatility could throw some caution flags. Long-term growth expectations for small caps, though improved, still remain below average.</p>
<p>Bank of America's credit strategists predict that 2025 could be a better year for M&amp;A activity as rate cuts begin to materialize and volatility subsides. </p>
<p>"Sponsors are sitting on a pile of uncalled capital, and there's a real incentive to deploy it in a friendlier economic environment," Hall said.</p>
<h3 class="wp-block-heading">Who Stands To Gain: Small-Cap Targets, Large-Cap Acquirers</h3>
<p>With large deals on the decline, smaller targets have become the prime candidates for takeovers. </p>
<p>Aggregate deal value has been falling in recent years as mega-cap deals have dried up and smaller, more manageable transactions have become the norm.</p>
<p>This trend has paid off for both sides: small-cap targets have outperformed post-announcement and large-cap acquirers have seen record one-day gains in 2023 despite paying higher deal premiums.</p>
<p>This pattern suggests that investors are rewarding companies that buy growth, especially in today's uncertain economic landscape.</p>
<h3 class="wp-block-heading">10 <strong>Potential M&amp;A Candidates</strong> Among Large Caps</h3>
<p>Bank of America's latest screening of potential M&amp;A candidates includes high-growth, undervalued names, each with distinct value propositions that may appeal to suitors looking for long-term growth.</p>
<p><figure class="wp-block-table is-style-stripes"><br />
<table>
<thead>
<tr>
<th>Company</th>
<th>Sector</th>
<th>Market Cap ($M)</th>
<th>Free Cash Flows-to-Enterprise Value (%)</th>
<th>Long-Term Growth Expectations (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Universal Health Services Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>)</td>
<td>Health Care</td>
<td>13,932</td>
<td>4.4</td>
<td>25.3</td>
</tr>
<tr>
<td><strong>Ralph Lauren</strong> <strong>Corp.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RL#NYSE">RL</a>)</td>
<td>Consumer Disc.</td>
<td>12,473</td>
<td>5.99</td>
<td>10.5</td>
</tr>
<tr>
<td><strong>Paramount Global</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NYSE">PARA</a>)</td>
<td>Comm. Services</td>
<td>7,250</td>
<td>3.4</td>
<td>46.4</td>
</tr>
<tr>
<td><strong>Jabil Inc. </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>)</td>
<td>Technology</td>
<td>14,480</td>
<td>6.39</td>
<td>12.7</td>
</tr>
<tr>
<td><strong>Hasbro Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAS#NASDAQ">HAS</a>)</td>
<td>Consumer Disc.</td>
<td>9,215</td>
<td>3.6</td>
<td>27.5</td>
</tr>
<tr>
<td><strong>F5 Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>)</td>
<td>Technology</td>
<td>13,431</td>
<td>6.39</td>
<td>9.9</td>
</tr>
<tr>
<td><strong>DaVita Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>) </td>
<td>Health Care</td>
<td>11,976</td>
<td>5.39</td>
<td>15.4</td>
</tr>
<tr>
<td><strong>BorgWarner</strong> <strong>Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWA#NYSE">BWA</a>)</td>
<td>Consumer Disc.</td>
<td>7,316</td>
<td>6.5</td>
<td>12.0</td>
</tr>
<tr>
<td><strong>Aptiv plc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>)</td>
<td>Consumer Disc.</td>
<td>13,143</td>
<td>4.4</td>
<td>23.7</td>
</tr>
<tr>
<td><strong>A. O. Smith</strong> <strong>Corp.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>)</td>
<td>Industrials</td>
<td>10,895</td>
<td>2.3</td>
<td>10.0</td>
</tr>
</tbody>
</table>
<p></p></figure></p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41950023/us-stock-markets-equity-risk-premium-disappears-should-you-sell-now">US Stock Market&#8217;s Equity Risk Premium Disappears: Should You Sell Now?</a></strong></li>
</ul>
<p><em>Photo by Capri23auto from Pixabay</em></p>


Analyst Color

Large Cap

Small Cap

Federal Reserve

Golden Years For M&A Deals Ahead Under Trump? Analysts Highlight Top 10 Large-Cap Candidates

<p>A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $83.0, along with a high estimate of $91.00 and a low estimate of $80.00. This current average is unchanged from the previous average price target. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1729710059_0_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>A comprehensive examination of how financial experts perceive A.O. Smith is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$91.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Michael Halloran</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$81.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Damian Karas</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$80.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Matt Summerville</td>
<td>DA Davidson</td>
<td>Announces</td>
<td>Neutral</td>
<td>$80.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to A.O. Smith. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of A.O. Smith compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of A.O. Smith's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>To gain a panoramic view of A.O. Smith's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/AOS/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on A.O. Smith analyst ratings.</strong></a></p>
<h2>Get to Know A.O. Smith Better</h2>
<p>A.O. Smith Corporation manufactures and markets comprehensive lines of residential and commercial gas, gas tankless, and electric water heaters. Supplementary products include water heating equipment, condensing and noncondensing boilers, and water system tanks. The company's two operating segments are by geographic region: North America (majority of total revenue) and the Rest of the World. A material portion of sales in North America derive from replacing existing products, and the company utilizes a wholesale distribution channel and multiple selling locations. The Rest of the World segment sells majorly in Asian countries and operates sales offices to expand distribution and market its product portfolio.</p>
<h3>A.O. Smith's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Positive Revenue Trend:</strong> Examining A.O. Smith's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>6.61%</strong> as of 30 June, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> A.O. Smith's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of <strong>15.25%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> A.O. Smith's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>8.24%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> A.O. Smith's ROA excels beyond industry benchmarks, reaching <strong>4.9%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> A.O. Smith's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.09</strong>.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


A Closer Look at 4 Analyst Recommendations For A.O. Smith

<p>Stifel  analyst Nathan Jones   maintains A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) with a Buy and lowers the price target from $92 to $91.</p>


Stifel Maintains Buy on A.O. Smith, Lowers Price Target to $91

Press Releases

A. O. Smith Reports Third Quarter Performance

Commodities

A. O. Smith Acquires Pureit

A. O. Smith Corporation Publishes 2024 Sustainability Report

A. O. Smith to Hold Fourth Quarter Conference Call on January 30, 2025

RPM Announces Appointment of Three New Board Members

Dividends

A. O. Smith Reports Quarterly Dividend

A. O. Smith Reports 2024 Results and Introduces 2025 Guidance

Ethisphere Names A. O. Smith Corporation One of the 2025 World's Most Ethical Companies® for the Second Time

Comments

A.O. Smith

Notizie

Ultime notizie per A.O. Smith (NYSE:AOS) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO